HAAC has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
HAAC has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Risk Assessment represents the investment risk of a stock derived from our exclusive method. It suggests how risky the investment opportunity is based on the valuation and the fundamental performance of the stock. It is derived from following key aspects:
1. GuruFocus internally developed valuations of the stock, such as GF valuation.Value investors are always willing to find undervalued stocks. However, not all the undervalued stocks are good deals, we should also be careful of how risky the investment opportunity is. We believe that if the company's financial strength and profitability are strong, and the stock price is within a reasonable range of the GF valuation, or stock has a high return with its price being undervalued, then it might be a good investment opportunity with low risk.
Based on those aspects listed above, GuruFocus believes the risk assessment of Health Assurance Acquisition is: No Data: Cannot be evaluated.
For the Shell Companies subindustry, Health Assurance Acquisition's Risk Assessment, along with its competitors' market caps and Risk Assessment data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Diversified Financial Services industry and Financial Services sector, Health Assurance Acquisition's Risk Assessment distribution charts can be found below:
* The bar in red indicates where Health Assurance Acquisition's Risk Assessment falls into.
Health Assurance Acquisition (NAS:HAAC) Risk Assessment Explanation
Based on the four aspects listed above, GuruFocus provides the following 7 evaluations:
(1) These are some simple examples. You can access our Risk Assessment filter under All-in-One Screener’s Fundamental tab and set your own criteria.
Thank you for viewing the detailed overview of Health Assurance Acquisition's Risk Assessment provided by GuruFocus.com. Please click on the following links to see related term pages.
Atlas Merchant Capital Llc | 10 percent owner | 477 MADISON AVENUE, 22ND FLOOR, NEW YORK NY 10022 |
Mark Joseph Allen | officer: Chief Financial Officer | 20 UNIVERSITY ROAD, CAMBRIDGE MA 02138 |
Michelle A Brown | officer: Chief Financial Officer | C/O HEALTH ASSURANCE ACQUISITION CORP., 20 UNIVERSITY ROAD, CAMBRIDGE MA 02138 |
Klasko Stephen K. M.d. | director | 155 SOUTH LIMERICK ROAD, LIMERICK PA 19468 |
Anita Pramoda | director | 222 MERCHANDISE MART PLAZA, SUITE 2024, CHICAGO IL 60654 |
Glen Tullman | director | C/O LIVONGO HEALTH, INC., 150 WEST EVELYN AVENUE, SUITE 150, MOUNTAIN VIEW CA 94041 |
Quentin Clark | director | 333 BRANNAN STREET, SAN FRANCISCO CA 94107 |
Hemant Taneja | director, officer: Chief Executive Officer | C/O GENERAL CATALYST, 20 UNIVERSITY ROAD, 4TH FLOOR, CAMBRIDGE MA 02138 |
Jennifer Schneider | director | C/O LIVONGO HEALTH, INC., 150 WEST EVELYN AVENUE, SUITE 150, MOUNTAIN VIEW CA 94041 |
Evan Sotiriou | officer: Chief Operating Officer | C/O HEALTHCARE ASSURANCE ACQUISITION, 20 UNIVERSITY ROAD, FOURTH FLOOR, CAMBRIDGE MA 02138 |
Health Assurance Economy Foundation | 10 percent owner | 20 UNIVERSITY ROAD, FOURTH FLOOR, CAMBRIDGE MA 02138 |
Haac Sponsor, Llc | 10 percent owner | C/O GENERAL CATALYST, 20 UNIVERSITY ROAD, FOURTH FLOOR, CAMBRIDGE MA 02138 |
From GuruFocus
By Marketwired Marketwired • 12-31-2020
By Marketwired Marketwired • 06-05-2021
By Value_Insider Value_Insider • 10-27-2022
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.